Cross-Canada Survey of Resistance of 2747 Aerobic Blood Culture Isolates to Piperacillin/Tazobactam and Other Antibiotics

Kevin R Forward; Patricia A Franks; Donald E Low; Robert Rennie; Andrew E Simor; the Canadian Piperacillin/Tazobactam Study Group

doi:10.1155/1998/730838

Canadian Journal of Infectious Diseases (Jan 1998)

Cross-Canada Survey of Resistance of 2747 Aerobic Blood Culture Isolates to Piperacillin/Tazobactam and Other Antibiotics

Kevin R Forward,
Patricia A Franks,
Donald E Low,
Robert Rennie,
Andrew E Simor,
the Canadian Piperacillin/Tazobactam Study Group

Affiliations

Kevin R Forward: Division of Microbiology, Department of Pathology and Laboratory Medicine, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada
Patricia A Franks: Department of Microbiology and Infectious Diseases, Hôpital Maisoneuve-Rosemont, Montréal, Québec, Canada
Donald E Low: Microbiology and Public Health, University of Alberta Hospital, Edmonton, Alberta, Canada
Robert Rennie: Wyeth-Ayerst Canada Inc, Toronto, Ontario, Canada
Andrew E Simor: Department of Microbiology, Mount Sinai & Princess Margaret Hospitals, Toronto, Ontario, Canada
the Canadian Piperacillin/Tazobactam Study Group: Department of Microbiology, Sunnybrook Health Science Centre, Toronto, Ontario, Canada

DOI: https://doi.org/10.1155/1998/730838
Journal volume & issue: Vol. 9, no. 1
pp. 33 – 44

Abstract

Read online

OBJECTIVE: To compare the activity of piperacillin/tazobactam with that of other broad parenteral antibiotics against aerobic and facultative anaerobic blood culture isolates in a Canada-wide survey.

Published in Canadian Journal of Infectious Diseases

ISSN: 1180-2332 (Print)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Infectious and parasitic diseases
Website: https://onlinelibrary.wiley.com/journal/9575

About the journal